Medopad

Health tech company collaborating with healthcare systems & pharma companies.

At Medopad, we want to create a world where people can live longer. A world where the best minds continue doing their best work. A world where we can spend more time with our loved ones. We work to transform patient care pathways, improve standard of care, and kickstart new clinical research; our patient facing app provides a secure platform for patients to share data with their clinician. Our technology takes a modular approach which means we cover a wide variety of disease areas to deliver better and more personalised care by transforming the way patients and data interact with clinicians. Our Artificial Intelligence division uses data collected through our platform to generate predictive insights which will be able to detect life threatening medical conditions. We partner closely with the world’s largest healthcare systems, pharma companies, research institutes, insurers and technology companies like Apple and Tencent to solve some of the biggest problems in rare, chronic and complex disease monitoring. Medopad was recently named a $1 billion health tech company in the making by KPMG. Medopad provides an app-based solution to support clinical service in rare disease and chronic disease. Our solution can be configured to work with any clinical service area, and examples of areas we are working in today include: Cardiology: Pulmonary Arterial Hypertension Haematology: Splanchnic Vein Thrombosis Oncology: Diffuse Intrinsic Pontine Glioma Renal: Complex Glomerulonephritis Neurology: Parkinson's